Preferred Label : Preeclampsia/eclampsia 1;
Symbol : PEE1;
CISMeF acronym : HELLP; PEE; PEE1; PREG1;
Type : Phenotype or locus, molecular basis unknown;
Alternative titles and symbols : Toxemia of pregnancy; PREG1; PEE;
Included titles and symbols : Hypertension, pregnancy-induced; Hemolysis, elevated liver enzymes, and low platelet count; HELLP;
Description : Preeclampsia, which along with chronic hypertension and gestational hypertension comprise
the hypertensive disorders of pregnancy, is characterized by new hypertension (blood
pressure 140/90 or greater) presenting after 20 weeks' gestation with clinically relevant
proteinuria. Preeclampsia is 1 of the top 4 causes of maternal mortality and morbidity
worldwide (summary by Payne et al., 2011). Preeclampsia is otherwise known as gestational
proteinuric hypertension (Davey and MacGillivray, 1988). A high proportion of patients
with preeclampsia have glomerular endotheliosis, the unique histopathologic feature
of the condition (Fisher et al., 1981). A distinct form of severe preeclampsia is
characterized by hemolysis, elevated liver enzymes, and low platlets (HELLP syndrome)
(Brown et al., 2000). - Genetic Heterogeneity of Preeclampsia/Eclampsia Susceptibility
loci for preeclampsia/eclampsia include PEE1 on chromosome 2p13, PEE2 (609402) on
chromosome 2p25, and PEE3 (609403) on chromosome 9p13. PEE4 (609404) is caused by
mutation in the STOX1 gene (609397) on chromosome 10q22. PEE5 (614595) is caused by
mutation in the;
Inheritance : Autosomal dominant;
Laboratory abnormalities : Proteinuria; Elevated liver enzymes;
Prefixed ID : %189800;
Origin ID : 189800;
UMLS CUI : C5574918;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
False automatic mappings
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT